Levin Associates counted 106 physician medical group deals in the second quarter of 2026. That is down from 124 in the first quarter as restated in the same July release, and down from the 145 that Levin first reported for Q1 in April.
Across the six quarters from Q1 2025 to Q2 2026, the first-reported quarterly count ran from a low of 106 to a high of 145. Levin tracks publicly announced transactions in its LevinPro HC database, so the counts cover deals that reached a press release or filing.
Physician medical group deals by quarter
The table lists each quarter as Levin first reported it. The six first-reported counts add up to 745 deals, by my sum. Levin put the Q4 2025 count at 138, up 20% from 115 in Q4 2024. It put the Q3 2025 count at 130, up 13% from 115 in Q3 2024.
| Quarter | All healthcare deals | Physician medical group deals | Levin release date |
|---|---|---|---|
| Q1 2025 | 480 | 109 | April 17, 2025 |
| Q2 2025 | 489 | 117 | July 17, 2025 |
| Q3 2025 | Not stated | 130 | October 17, 2025 |
| Q4 2025 | 530 | 138 | January 14, 2026 |
| Q1 2026 | 549 | 145 | April 15, 2026 |
| Q2 2026 | 459 | 106 | July 30, 2026 |
Source: Levin Associates quarterly releases from LevinPro HC, figures as first reported in each release.
How physician groups compare with all healthcare deals
Physician medical groups led all sectors in Q2 2026 with 106 deals, or 23% of the 459 transactions Levin counted. Total volume fell about 23% from 503 in Q2 2025. In Q1 2025, physician groups (109 deals) outnumbered eHealth (77) and medical outpatient buildings (49). In Q1 2026, Levin counted 549 deals across 17 sectors, with physician groups ahead of medical outpatient buildings (69), home health and hospice (34) and behavioral health care (24).
Levin reported 2,139 healthcare deals for all of 2025, against 2,059 in 2024. Disclosed spending in Q2 2026 reached $95.3 billion across 78 deals, compared with $28.7 billion in Q2 2025. Deals above $1 billion numbered 21 in Q2 2026, against 13 in Q1 2026. Q4 2025 disclosed spending was $120.2 billion across 98 deals, and Q1 2026 was $73.58 billion. Most of that dollar total comes from large transactions outside physician practices.
Who is buying physician groups
Private equity firms and their portfolio companies announced 151 healthcare deals in Q2 2026, a 33% share of all deals. Physician medical groups made up 59 of those, or 39% of private equity activity. In Q1 2025, private equity announced 166 deals, 66 of them in physician groups, nearly 40% of its activity.
| Quarter | Private equity deals, all healthcare | Share of all deals | Private equity physician group deals |
|---|---|---|---|
| Q1 2025 | 166 | 35% | 66 |
| Q2 2025 | 148 | Not stated | 56 |
| Q4 2025 | 153 | 29% | Not stated |
| Q2 2026 | 151 | 33% | 59 |
Source: Levin Associates releases of April 15, 2025, July 15, 2025, January 14, 2026 and July 30, 2026, as first reported. Q3 2025 states no private equity count, and the Q1 2026 release (181 deals) and the July 2026 release (150 deals) disagree, so those quarters are left out.
Dental drives much of that activity. In Q1 2025, 33 of private equity's physician group deals were dental, or 50% of its physician group acquisitions. Within physician groups, private equity accounted for 48% of transactions in Q3 2025, per Levin. The share in Q3 2024 was more than 52%.
Health systems announced 30 deals in Q2 2026, up from 22 in Q2 2025, and six of them were physician group deals. In Q4 2025 health systems announced 40 deals, 10 of them physician groups. In Q3 2025 they bought physician groups in 8 transactions across seven states. Independent physician groups, as a buyer type, announced 27 acquisitions in Q3 2025.
Which specialties change hands
Dental practices account for about half of the physician medical group count. Levin recorded 66 dental deals in Q3 2025, just over half of that quarter's 130. It recorded 52 in Q4 2025 and 54 in Q2 2026. Subtracting dental from the totals, by my calculation, leaves 64 other deals in Q3 2025, 86 in Q4 2025 and 52 in Q2 2026.
Among the remaining specialties, counts per quarter are small. Q3 2025 had 9 orthopaedic, 8 eye care, 8 dermatology and 1 oncology deal. Q4 2025 had 9 orthopaedic and 9 OB/GYN deals. Q2 2026 had 7 internal medicine and 6 pediatrics deals.
Why a quarter's count changes after release
Levin revises counts as it finds more announcements. The Q1 2026 physician group count was 145 in the April release and 124 in the July release, a change of 21 deals. The Q3 2025 count moved from 130 to 137 in the Q4 2025 release. The Q2 2025 count moved from 117 to 119, and the Q1 2025 count from 109 to 115.
Three of those four restated counts went up. The Q1 2026 count went down. Totals move too: Q1 2026 was 549 in April and 553 in July, and Q2 2025 was 489 in July 2025 and 503 in the 2026 release.
A practice leader who compares quarters should take every figure from one release, or from the latest release that covers all the quarters in question. Mixing first-reported counts, as the table above does, carries a margin of a few deals per quarter, with Q1 2026 the largest gap at 21. Against the 106 deals counted for Q2 2026, a 21-deal revision equals 19.8% of the quarter, so single-quarter swings of that size need a second release to confirm.
Sources
- Levin Associates, Healthcare M&A Stabilizes in Q1:25, April 17, 2025
- Levin Associates, Healthcare M&A Remained Steady in First Half of 2025, July 17, 2025
- Levin Associates, Private Equity Buyers Announce 166 Healthcare Deals in Q1:25, April 15, 2025
- Levin Associates, Physician Medical Group Deal Volume Increases in Q3:25, October 17, 2025
- Levin Associates, Healthcare Quarterly M&A Volume Decreases in Q4:25, January 14, 2026
- Levin Associates, Healthcare M&A Deal Volume Stalls in Q1:26, April 15, 2026
- Levin Associates, Healthcare M&A Deal Volume Drops in Q2:26, July 30, 2026
Talk to us
Fifteen minutes about your practice and the systems you run.